(Q43952214)

28 November 2017

title

The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinoma (English)

1 reference

28 November 2017

Jan Lehmann

1

1 reference

28 November 2017

Margitta Retz

2

1 reference

28 November 2017

Nils Nürnberg

3

1 reference

28 November 2017

Uta Schnöckel

4

1 reference

28 November 2017

Uta Raffenberg

5

1 reference

28 November 2017

Matthias Krams

6

1 reference

28 November 2017

Udo Kellner

7

1 reference

28 November 2017

Stefan Siemer

8

1 reference

28 November 2017

Klaus Weichert-Jacobsen

9

1 reference

28 November 2017

Michael Stöckle

10

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

28 November 2017

1 reference

28 November 2017

volume

101

1 reference

28 November 2017

issue

7

1 reference

28 November 2017

page(s)

1552-1562

1 reference

Metastatic renal carcinoma comprehensive prognostic system

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

A preoperative clinical prognostic model for non-metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

Self-report of smoking, obesity and hypertension history and survival among a cohort of iowa renal cell carcinoma cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

DNA content, nuclear grading and early tumor progression in renal cell cancer: a prospective study on frozen specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Current prognostic factors--renal cell carcinoma: Workgroup No. 4. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Does the Immunophenotype of Renal Cell Carcinoma Correlate with Its Clinical Stage?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Proliferating cell nuclear antigen: a new prognostic indicator in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Significance of conventional and new prognostic factors for locally confined renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Monoclonal antibodies Ki-S3 and Ki-S5 yield new data on the 'Ki-67' proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Role of platelets in tumor cell metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Platelet-derived growth factor. Structure, function and implications in normal and malignant cell growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Classic and modern prognostic indicators in renal cell carcinoma. Review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Obesity, hypertension, and the risk of kidney cancer in men

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Prognostic value of Ki-67 expression in renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Correlation between DNA ploidy, proliferation marker Ki-67 and early tumor progression in renal cell carcinoma. A prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Proliferating cell nuclear antigen and MIB-1. An alternative to classic prognostic indicators in renal cell carcinomas?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Prognostic value of cell proliferation (Ki-67 antigen) and nuclear DNA content in clinically resectable, distal bile duct carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20549

7 January 2021

Identifiers

DOI

10.1002/CNCR.20549

1 reference

28 November 2017

1 reference